Can you go home the same day after robotic hysterectomy? new study investigates
NCT ID NCT07233811
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two approaches after robotic hysterectomy: going home the same day versus staying overnight in the hospital. Researchers will track quality of life and complications over 30 days in 300 patients with benign conditions or endometrial cancer. The goal is to see if same-day discharge is safe and helps patients recover faster.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that same-day discharge after robotic hysterectomy is safe and leads to faster recovery, potentially changing standard hospital practice.
- What could go wrong
- This is a relatively small, early-stage trial (300 participants) and results may not apply to all patients or hospitals. Complications or lower quality of life in the day-care group could limit adoption.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient that are planned to undergo total robotic hysterectomy with or without adnexal surgery at the three sites. * Both benign conditions and endometrial cancer. * All BMI groups and all uterus sizes. Exclusion Criteria: * Age not over 75 years old, * No company at home first night after surgery * ASA class 3 that is not only because of high BMI. * Simultaneous prolapse surgery/lymph node evacuation. * Severe endometriosis or patients with chronic pain conditions that have a special pain regimen after surgery.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign uterine disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Danderyd Hospital
RECRUITINGStockholm, Sweden
-
Karolinska University hospital
RECRUITINGStockholm, Sweden
-
Södersjukhuset
RECRUITINGStockholm, 11447, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One small incision vs several: robotic stomach cancer surgery put to the test
- Shorter, personalized radiation may target endometrial cancer with fewer side effects
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?
- Can a Weight-Loss drug and an IUD treat early uterine cancer without surgery?
- Your gut bacteria may hold the key to whether immunotherapy works
- Can a guided missile for chemo hit tumors harder and spare healthy tissue?